338 related articles for article (PubMed ID: 31917418)
1. Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.
Webster L; Gudin J; Raffa RB; Kuchera J; Rauck R; Fudin J; Adler J; Mallick-Searle T
Pain Med; 2020 Apr; 21(4):714-723. PubMed ID: 31917418
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Continuous Perioperative Sublingual Buprenorphine.
Silva MJ; Rubinstein A
J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):289-293. PubMed ID: 27736284
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine for Pain: A Narrative Review and Practical Applications.
Spinella S; McCarthy R
Am J Med; 2024 May; 137(5):406-413. PubMed ID: 38340973
[TBL] [Abstract][Full Text] [Related]
5. Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.
Lundorff L; Sjøgren P; Hansen OB; Jonsson T; Nielsen PR; Christrup L
J Opioid Manag; 2013; 9(4):255-62. PubMed ID: 24353018
[TBL] [Abstract][Full Text] [Related]
6. Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process.
Goel A; Azargive S; Weissman JS; Shanthanna H; Hanlon JG; Samman B; Dominicis M; Ladha KS; Lamba W; Duggan S; Di Renna T; Peng P; Wong C; Sinha A; Eipe N; Martell D; Intrater H; MacDougall P; Kwofie K; St-Jean M; Rashiq S; Van Camp K; Flamer D; Satok-Wolman M; Clarke H
Br J Anaesth; 2019 Aug; 123(2):e333-e342. PubMed ID: 31153631
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine buccal film for chronic pain management.
Hale M; Gimbel J; Rauck R
Pain Manag; 2020 Jul; 10(4):213-223. PubMed ID: 32394800
[TBL] [Abstract][Full Text] [Related]
8. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
9. Demystifying Buprenorphine with Current Evidence-Based Practice in Acute and Chronic Pain Management.
Giron SE; Lai G; Griffis CA; Zhang SJ
AANA J; 2022 Jun; 90(3):225-233. PubMed ID: 35604865
[TBL] [Abstract][Full Text] [Related]
10. The utilization of buprenorphine in chronic pain.
Urits I; Pham C; Swanson D; Berardino K; Bandi P; Amgalan A; Kaye RJ; Jung JW; Kaye AD; Paladini A; Varrassi G; Kaye AM; Manchikanti L; Viswanath O
Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):355-368. PubMed ID: 33004153
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine: considerations for pain management.
Johnson RE; Fudala PJ; Payne R
J Pain Symptom Manage; 2005 Mar; 29(3):297-326. PubMed ID: 15781180
[TBL] [Abstract][Full Text] [Related]
12. Treating Chronic Pain with Buprenorphine-The Practical Guide.
Case AA; Kullgren J; Anwar S; Pedraza S; Davis MP
Curr Treat Options Oncol; 2021 Nov; 22(12):116. PubMed ID: 34791564
[TBL] [Abstract][Full Text] [Related]
13. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
van Niel JC; Schneider J; Tzschentke TM
Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
16. Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
Patel KV; Sahni S; Taylor LF
J Osteopath Med; 2023 Jan; 123(1):1-5. PubMed ID: 36282967
[TBL] [Abstract][Full Text] [Related]
17. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.
Gudin J; Fudin J
Pain Ther; 2020 Jun; 9(1):41-54. PubMed ID: 31994020
[TBL] [Abstract][Full Text] [Related]
18. Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.
Withey SL; Spealman RD; Bergman J; Paronis CA
J Pharmacol Exp Ther; 2019 Nov; 371(2):544-554. PubMed ID: 31413139
[TBL] [Abstract][Full Text] [Related]
19. Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients.
Daitch D; Daitch J; Novinson D; Frey M; Mitnick C; Pergolizzi J
Pain Med; 2014 Dec; 15(12):2087-94. PubMed ID: 25220043
[TBL] [Abstract][Full Text] [Related]
20. When opioids fail in chronic pain management: the role for buprenorphine and hospitalization.
Berland DW; Malinoff HL; Weiner MA; Przybylski R
Am J Ther; 2013; 20(4):316-21. PubMed ID: 23584313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
